miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential

Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors worldwide. Clinical success is suboptimal owing to late diagnosis, limited treatment options, high recurrence rates, and the development of drug resistance. MicroRNAs (miRNAs), a range of small endogenous non-coding RNAs t...

Full description

Bibliographic Details
Main Authors: Hang Yan, Shengjie Tang, Shoujun Tang, Jun Zhang, Haiyang Guo, Chao Qin, Haiyang Hu, Chuan Zhong, Li Yang, Yunhe Zhu, Haining Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pharmacology
Subjects:
drug resistance
miRNA
NSCLC
therapy
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.949566/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.949566/full

Similar Items